U.S. License Holder:
Viokace LLC
Date of License:
May-01-2012
Last Update:
Nov-30-2023
FDA-Approved Indications
VIOKACE (pancrelipase (amylase; lipase; protease)) is a combination of porcine-derived lipases, proteases, and amylases. VIOKACE, in combination with a proton pump inhibitor, is indicated in adults for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy.